VOYA Investment Management’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,274
Closed -$69.7K 2440
2025
Q2
$69.7K Buy
+12,274
New +$69.9K ﹤0.01% 2552
2021
Q2
Sell
-1,208
Closed -$57K 2802
2021
Q1
$57K Hold
1,208
﹤0.01% 2735
2020
Q4
$47K Buy
1,208
+351
+41% +$12K ﹤0.01% 2658
2020
Q3
$22K Hold
857
﹤0.01% 2493
2020
Q2
$62K Sell
857
-117
-12% -$8.09K ﹤0.01% 2418
2020
Q1
$51K Buy
974
+256
+36% +$17.1K ﹤0.01% 2487
2019
Q4
$59K Buy
718
+199
+38% +$14K ﹤0.01% 2626
2019
Q3
$29K Hold
519
﹤0.01% 2532
2019
Q2
$62K Hold
519
﹤0.01% 2542
2019
Q1
$95K Hold
519
﹤0.01% 2431
2018
Q4
$93K Hold
519
﹤0.01% 2414
2018
Q3
$166K Hold
519
﹤0.01% 2393
2018
Q2
$208K Buy
519
+21
+4% +$9.18K ﹤0.01% 2338
2018
Q1
$179K Hold
498
﹤0.01% 2353
2017
Q4
$197K Buy
498
+53
+12% +$21.9K ﹤0.01% 2353
2017
Q3
$190K Buy
+445
New +$120K ﹤0.01% 2398

Other funds holding ABEO

VOYA Investment Management's ABEO Position: Q3 2025 in Review

VOYA Investment Management sold out of Abeona Therapeutics (ABEO) in Q3 2025, closing a stake of 12,274 shares — an estimated $69.7K sold.

VOYA Investment Management first reported a position in ABEO in Q3 2017 and held it in 16 quarters. The position peaked at $208K in Q2 2018. 100 funds tracked by Wall St. Rank hold ABEO as of Q3 2025.

  • VOYA Investment Management reported no remaining Abeona Therapeutics position as of Q3 2025 after selling out during the quarter.
  • VOYA Investment Management sold 12,274 Abeona Therapeutics shares in Q3 2025, an estimated $69.7K.
  • VOYA Investment Management first reported a position in Abeona Therapeutics in Q3 2017 and held it in 16 quarters.
  • VOYA Investment Management's Abeona Therapeutics position peaked at $208K in Q2 2018.
  • 100 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2025.

Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.